system imposed an undue regulatory and administrative burden on investigators and had arbitrary entry criteria that restricted enrollment. 1 , 2 The COVID-19 pandemic has disrupted all aspects of social, work, and economic life throughout the world. 3 , 4
Search Results
Martin J. Edelman, Crystal S. Denlinger, Eric A. Ross, and Margaret von Mehren
Sheetal Kircher, Nicole Braccio, Kathleen Gallagher, Ruth Carlos, Lynne Wagner, Mary Lou Smith, Alan Balch, and Al B. Benson III
The COVID-19 pandemic broadly curtailed access to cancer care and highlighted the need to meet patients “where they are,” which included remote access provisions. This need triggered multiple policy changes in 2020 that have accelerated adoption
Zhiyuan Zheng, Stacey A. Fedewa, Farhad Islami, Leticia Nogueira, Xuesong Han, Jingxuan Zhao, Weishan Song, Ahmedin Jemal, and K. Robin Yabroff
, rapidly evolving COVID-19 pandemic, which has caused major disruptions in almost all economic sectors, including the food supply chain. Our results showed that lack of paid sick leave was especially common among cancer survivors working in industries
Adam C. Powell, Logan Horrall, James W. Long, and Amin J. Mirhadi
2021: a period capturing healthcare before the COVID-19 pandemic, the pre-vaccination phase, and the post-vaccination phase. Methods: Claims for lung cancer treatment made between 2019 and 2021 were extracted from the database of a national healthcare
Michelle C Simpson and Danell J Haines
INTRODUCTION : The advent of the COVID-19 pandemic has highlighted the need to expand options for home-based cancer care. For 40 years, millions of patients have selected the home setting to administer infused medications citing improved quality
Lilian Hanna, Gordon Taylor Moffat, Wilma Hopman, Pierre-Olivier Gaudreau, and Andrea S. Fung
exploring alternate dosing schedules. The COVID-19 pandemic created a need to cut down on patient visits, thus allowing incorporation of extended dosing (ED) of durvalumab (20mg/kg IV every 4 weeks) into clinical practice. The current study evaluates real
biases in care, and taking on social determinants of health. Of course, all of these conversations are happening in the shadow of the COVID-19 pandemic, which has exposed systemic problems and radically changed care delivery.” The COVID-19 pandemic and
Annie L Zhang, Jaime Abraham Perez, and Melinda Hsu
number of patients screened in the two cohorts from TriNetX. This difference is likely due to an increase in the number of HCOs contributing data as time passed and COVID-19 pandemic effects on healthcare utilization. This study found no significant
Kedar Kirtane, Jameel Muzaffar, Julie Kish, Laura B Oswald, Brian D Gonzalez, Taylor Welniak, Yvelise Rodriguez, and Christine H Chung
to worsening of their medical condition. Due to the COVID-19 pandemic, the trial was closed for the eight months but is now open to accrual. Conclusions : This trial is currently open and accruing patients. Feasibility will be analyzed after
Gene A. Wetzstein, Dima Decker, and James Mond
COVID 19 pandemic; (2) identify the most common respiratory viral pathogens; (3) explore current management approaches and prescriber satisfaction; and (4) explore unmet need and future therapies. Methods: This prospective medical questionnaire was
